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Summary 
The origin of autoreactive CD4-CD8- T cells is largely 
unknown. In TCR transgenic (Tg) mice expressing the 
cognate class I MHC antigen, CD4-CD8-T cells differed 
depending on characteristics of Tg-TCRlantigen inter- 
action. Tg-TCR/CDP’ CD4CD8- T cells expressing the 
NKl .l marker were observed only for a Tg-TCR whose 
stimulation by antigen was independent of CD8. Unlike 
normal T cells, which have essentially TCR-associated 
5 homodimers, these cells had a high proportion of 
TCR-associated &-FceRly heterodimers. They were 
also characterized by an unusually high content of 
FcsRly mRNA and low content of mRNA encoding 
CD3&, CDBy, CD36, and r;. Based on their phenotype 
and selection requirements, it is proposed that 
CD4-CD8- thymic precursor cells can be driven along 
the CDCCDCNKl .l + pathway following coreceptor- 
independent TCR signaling at an intrathymic stage 
when FceRly and CD3 components are coexpressed. 
The main pathway for T cell receptor (TCR)af3 T cell devel- 
opment involves their intrathymic differentiation to 
CD3r°CD4+CD8+ thymocytes. Upon appropriate selec- 
tion, these further differentiate to CD3hiCD4+CD8- or 
CD3hiCD4-CD8+ medullary thymocytes (von Boehmer, 
1992; Chan et al., 1993; Godfrey and Zlotnik, 1993) that 
constitute, respectively, the class II- and class l-restricted 
effector T cells in peripheral lymphoid organs. Their sur- 
face TCR-CD3 complex is composed of (Clevers et al., 
1988): a disulfide-linked TCRa6 heterodimer, noncova- 
lently associated pairs of CD3.cCD38 and CD3&CD3y, and 
disulfide-linked dimersof c, for the majority in homodimeric 
c-c form with a small proportion (less than 10%) in 6-n 
form (Baniyash et al., 1988). The <-)J,-n dimers can be 
replaced by c-FcERI~ heterodimers or FcsRly homodimers 
in some instances (Orloff et al., 1990; Vivier et al., 1991; 
‘The two first authors contributed equally to this work. 
Koyasu et al., 1992; Mizoguchi et al., 1992; Guy-Grand 
et al., 1994). 
In mice transgenic (Tg) for a TCRa8 specific for a class 
I MHC antigen, thymic precursor cells differentiate along 
the main TCRaf3 pathway to generate CD4-CD8’ lineage 
Tcells(Shaetal., 1988;Tehetal., 1988)Thisiscontingent 
upon a differentiation event requiring expression of the 
CD8 coreceptor and the appropriate MHC selecting com- 
ponent in the thymus that generatesTCR/CD3hiCD4-CD8+ 
T cells (Sha et al., 1988; Teh et al., 1988). These migrate to 
the periphery as naive precursor cells and, upon antigenic 
stimulation, they acquire activation markers and cytolytic 
function. The presence of the cognate class I MHC antigen 
in the thymus of the Tg-TCR mice precludes the develop- 
ment of these T cells. Instead, the Tg-TCR is found ex- 
pressed in the periphery of these mice essentially on 
CD4CD8’“‘-T cells (Kisielow et al., 1988; Shaet al., 1988; 
Auphan et al., 1992, 1994). The possible relationship be- 
tween these T cells expressing an autoreactive TCR (Rus- 
sell et al., 1990; von Boehmer et al., 1991) and CD4-CD8- 
TCR’ T cell subsets present in normal or in pathological 
nontransgenic situations has not been clarified. In particu- 
lar, in both humans (Porcelli et al., 1993; Dellabonaet al., 
1994) and mice (Fowlkes et al., 1987; Makino et al., 1993; 
Lantz and Bendelac, 1994) a CD4-(4+)/CD8- T cell popula- 
tion characterized by a restricted TCR V gene usage has 
recently been identified. In mice, mature thymocytes with 
this restricted V gene repertoire also expressed the natural 
killer NKl .l marker and a low level of surface CD3 (CD3’“). 
Their selection required expression of a nonpolymorphic 
class I MHC product on hematopoietic cells (Bix et al., 
1993; Bendelac et al., 1994; Coles and Raulet, 1994; Oh- 
teki and MacDonald, 1994) but did not require CD8 or 
CD4 coreceptor expression (Bendelac et al., 1994). 
We present evidence that CD4-CD8- T cells expressing 
an autoreactive TCR in Tg-TCR mice can have different 
characteristics. In one model, for which stimulation of the 
Tg-TCR by antigen is highly dependent on the contribution 
of CD8, the CD4-CD8- T cells expressed high surface 
TCR-CD3 complex and were NKl.l-. In the other, for 
which Tg-TCR stimulation occurred in the absence of CD8 
(Auphan et al., 1994), they expressed low surface TCR- 
CD3 and included NKl.l+ cells. Interestingly, the latter 
were found to express mainly <-FcERI~ heterodimers in 
association with the Tg-TCR, whereas the former ex- 
pressed the usual c-c homodimers. Comparison of the 
mRNA levels encoding CD~E, CDBT, CD36 r;, and FcERI~ 
in the different CD4CD8- T cell populations and of their 
surface marker expression in the thymus suggests that 
they originate from distinct intrathymic developmental 
stages/lineages. It is proposed that CD4-CD8- thymic pre- 
cursor cells can be driven along the CDCCDbNKl.1’ 
pathway following coreceptor-independent TCR signaling 
at a stage when FcERIT and CD3 components are coex- 
pressed. 
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non-Tg KB5.C20-Tg BM3.3-Tg KBS.C20-Tg BM3.3-Tg 
H-2* II.2a H.2m If.zkfb H.2km 
A. Thymus 
Total (x~O-~) 120 145 105 30 4 
%TCR+CD4-8- 0.7 6 7.7 5.5 17 
%NKI.l+ (*) 63 0.7 0 1.2 48 
B . Spleen 
-NKl.l 
Total (~10.~) 100 108 85 60 65 
% TCR+CD4-8 2.2 1.2 2.1 21 19 
%NKl.l+ ‘*) 10 4 6 7 53 
Figure 1. Comparison of TCR’ NKl .I+ T Cells in Thymus and Spleen of Normal Mice and of KB5.C20-Tg (CD&Dependent) or BM3.3-Tg (CD& 
Independent) Mice in the Absence or in the Presence of the Class I Antigen H-2@ 
Thymus or spleen populations were stained for the presence of NK1.l’ TCR’ lymphocytes. Flow cytofluorometric profiles are shown for the 
expression of NKl. 1 (abscissa) versus TCR for normal mice (non-Tg H-29, versus anticlonotype for KB5.C20-Tg H-2ti and H-2M and for BM3.3-Tg 
H-2Uk and H-2” after staining of total thymus (A) or spleen (6) cell suspensions. The percentage of NKI .l~ TCR’ and NKl .I + TCR’ cells is indicated 
for each sample, respectively in the left and right upper corner. (Asterisk) Numbers beneath each histogram represent the total cell number (x 
10-3, in the first lane; the percentage of cells that are CD4-CW and TCRf3’ (non-Tg) or Tg-TCR’ (Tg-KB5CPO and-BM3.3) in the second lane; 
the percentaoe of the TCR+CD4-CD8- cells that express the NK1.l marker, in the third lane. These numbers were calculated from the third color 
staining (anti-CD4 and anti-CD& both FITC conjugated). 
Results and Discussion 
Presence of CD4-CD8‘ T Cells with Surface NKl .l 
in Thymus and Spleen of Mice Expressing an 
Autoreactive Tg-TCR 
We have studied two models of Tg mice, which both ex- 
press a Tg-TCR specific for the class I alloantigen H-2Kb. 
The Tg-TCRs differ, however, in their dependence on the 
coreceptor CD8 for antigen-dependent triggering (Auphan 
et al., 1994; Curnow et al., 1994). Positive selection applies 
in H-2k mice, which express CD8 for both models (Curnow 
et al., 1994). When negatively selected in mice expressing 
the H-2Kb antigen, the Tg-TCR was found essentially on 
CD4-CD8- T cells (Curnow et al., 1994). The level of sur- 
face expression of the Tg-TCRICDS complex was signifi- 
cantly reduced on the CD4-CD8- T lymphocytes only in 
the CD8-independent model (Auphan et al., 1994; Curnow 
et al., 1994). Furthermore, about half of the thymic and 
splenic Tg-TCRICD3’ lymphocytes expressed the NKl .l 
marker in the CD8-independent model (Figure 1, see 
BM3.3-Tg H-2Ub), whereas most Tg-TCRICDB’ cells were 
NK1.V in the CD8-dependent model (Figure 1, see 
KB5.C20-Tg H-2Wb). In H-2”” Tg-TCR mice, the NK1.l 
marker was expressed on less than 1% of Tg-TCR’thymo- 
cytes and less than 2% of Tg-TCR+ splenic T cells in both 
models. Nontransgenic H-2k’b mice expressed less than 
2% NK1.1’ T cells in both thymus and spleen (Figure 1). 
Since the representation of TCR+CD4-CD8- cells varies 
in these different samples, it is particularly relevant to 
compare the percent of NKl .l+ cells among the 
TCR+CDCCD8-cells for each sample (Figure 1, see num- 
bers). In nontransgenic mice, where the proportion of 
TCR+CD4CD8- cells is particularly low in the thymus, a 
majority of these (63%) also expressed the NKl .l marker. 
In Tg-TCR mice, only for the CDSindependent Tg-TCR 
(BM3.3-Tg-TCR) were NKl .l+ cells selectively enriched 
among Tg-TCR+CD4-CDB-cells in both the thymus (48%) 
and periphery (53%) of H-2”b mice (Figure 1). 
To characterize further the NKl .l+ population, the ex- 
pression of maturation/activation markers was analyzed. 
Heterogeneity in Thymic Tg-TCR+CD4-CDB- 
Populations 
Expression of CD44, CD25 (interleukin-2Ra (IL-2Ra]), IL- 
2Rf3, and heat-stable antigen (HSA) surface markers was 
assessed on thymocytes expressing NK1.l in nontrans- 
genie or in BM3.3-Tg H-2Ub mice and on CD4-CD8- thymo- 
cytes lacking NK1.l expression in KB5.C20-Tg or 
BM3.3-Tg H-2k’b mice (Figure 2). All these gated popula- 
tions were negative for CD8, whereas CD4 was expressed 
on about half of the nontransgenic NKl.l+ thymocytes, 
but not at all on the three other populations analyzed (data 
not shown). All populations were negative for CD25 (IL- 
2Ra) and positive for IL9R6. The CD4-CD8- thymocytes 
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Figure 2. Phenotype of NKl .l+ Thymocytes in Normal Mice and of NKI .l- CD4-CD8- or NKl .l+ Thymocytes in Tg-TCR Mice in the Presence of 
the Class I Antigen H-2Kb 
Profiles are shown for 2,000 events recorded using a live gate on the PE channel to give either NKl .l+ or NKl .l- CD4-CD8- thymocytes as 
indicated. CD4 was expressed on about 60% of the non-Tg, but on none of the Tg-BM3.3 NKI .l+ thymocytes (data not shown). 
present in H-2Wb mice were heterogenous, however, in 
terms of their expression of the CD44 and HSA markers. 
The NKl .l+ T cells, whether normal or transgenic, were 
HSA-CD44-, compatible with an early CD4-CD8- pheno- 
type (Godfrey et al., 1993) whereas the KB5.C20-Tg 
CD4CD8- cells had a later maturation phenotype as 
HSA+CD44- (Godfrey et al., 1993). The BM3.3-Tg 
CD4-CD8-NKl .l-thymocytes had a heterogenous pheno- 
type intermediate between these two stages. 
Thus, the phenotype of nontransgenic and Tg-TCR 
NKl .l+ thymocytes was very similar with the exception of 
the expression of CD4 on some nontransgenic NK1.l’ 
thymocytes, in agreement with previous results (Bendelac 
et al., 1994). 
CD4-CD8- TCRICDB’“NK1 .l + T Cells Expressed 
Mostly l;-FccRly Heterodimers, Whereas 
CD4-CD8- TCR/CDBhiNK1.l- T Cells Expressed in 
Majority 1-5 Homodimers in Association 
with the Tg-TCR 
To evaluate the basis for TCRICD3 low expression on the 
NKl .I+ subset, biochemical analyses of immunoprecipi- 
tates of Tg-TCRs were performed on splenic T cells puri- 
fied as indicated in Figure 3. Results from two-dimensional 
gel electrophoresis of permeabilized radioiodinated Tg- 
TCR’ CD8+ T cells from H-2Wk mice and Tg-TCR’ 
CD4-CD8-T cells from H-2Wb mice showed that in all T cell 
populations the majority of c chain was in a c--r; homodimer 
form, except in the BM3.3-Tg-TCR/CD31° population, 
where c appeared associated with a molecule of lower 
weight (data not shown). This was shown to be Fc~Rly by 
immunoprecipitation of the Tg-TCR followed by blotting 
of nonreduced gels with either anti-r; (Figure 3A, left blot) 
or anti-FcsRly (Figure 3A, right blot) antibodies. The 5 com- 
ponent that was precipitated with the Tg-TCR was mostly 
(Figure 36, more than 95%) in the form of a 1; homodimer 
on CD8’ T cells in positive selection. For CD4CD8- 
KB5.C20-Tg T cells from H-2Wb mice, a very strong signal 
was apparent for L-T and a weak signal for t;-FcsRly, 
whether total or NKl .l- fractions were analyzed (Figure 
3A). The majority (more than 85%) of TCR-associated t 
was in the 6-6 form (Figure 38). In the BM3.3-Tg-TCRI 
CD3’” CD4-CD& cells, the &-< signals were low, particu- 
larly in the NKl .l+ fraction (Figure 3A, lane 7). However, 
the <-FccRly signal was the highest in that sample as com- 
pared with all other samples in absolute value and 72% 
TCR-associated L, was in the c-FcsRly heterodimer form in 
the NKl .l+ fraction as compared with 40% for the NKl .l- 
fraction (Figure 38). In addition to the higher usage of 
<-Fc~Rly in association with the TCR, the NKl .l+ T cells 
had a higher content of FcsRly protein not associated with 
the TCR than any of the other T cell populations analyzed; 
they also had the lowest total r; protein content (see next 
section; Figure 5). 
CD4-CD8- TCRICD3’“NKl .l + T Cells Express High 
FczRly mRNA and Protein and Low 6 and CD3 mRNA 
The use of FcsRly in the TCR-associated complex could 
be a consequence of the low amount of < or of the high 
amount of FcERI~ produced in the NKl.1’ T cells. The 
evaluation by Northern blot of different Tg-TCR’ splenic 
T cell populations (Figure 4) indicated that the two CD8+ 
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Figure 3. Comparison of TCR-Associated c and FceRly Chains in CD4-CD8+ Peripheral T Cells of H-2Uk Tg-TCR Mice and in CD4-CDE- Peripheral 
T Cells of H-2Wb TgTCR Mice, Before or After their Separation According to Expression of NKl.l 
Peripheral T cell populations were purified as described in Experimental Procedures and the following populations were analyzed: CDE’ T cells 
from H-2” KB5.C20-Tg (lane 1) and from BM3.3Tg (lane 4) mice; total (lane 2) and NKl .l~ (lane 3) CD4-CDE- T cells from KB5.C20-Tg H-2” 
mice; total (lane 5) NKl .l (lane 8) and NKl .l+ (lane 7) CD4-CD8- T cells from BM3.3-Tg H-2” mice. T cells were lysed:and anti-clonotype MAb 
immunoprecipitates were electrophoresed on SDS-PAGE in nonreduced conditions followed by blotting with anti< MAb (A, lefthand blot) or 
anti-FcsRly antiserum (A, righthand blot). Autoradiography (A) after revelation of specific antibody binding with ‘=I protein A shows the presence 
of 5-6 homodimers (arrow at 34 kDa [A]) in all samples, albeit only faintly in those from H-2” BM3.3-Tg CD4CD8-NKl .I+ (lane 7) and of c-FcsR1-r 
heterodimers (arrow at 25 kDa) in H-2Wb KB5.C20-Tg (lanes 2 and 3) and BM3.5Tg (lanes 5-7) samples (left and right). The strongest expression 
of <-FcsRly heterodimers was in the H-2” BM3.3-Tg CD4dD8- NKl .l+ sample (lane 7). This is also apparent on the anti-FcsRlv blot (righthand), 
where a clear signal is seen only in that sample (lane 7). No FcaRly homodimers (arrow at 20 kDa) were detected in any of the samples. Minor 
bands corresponding to c-n heterodimers (at 37 kDa) and to c-x (at 30 kDa, probably (;-~14; Taupin and Anderson, 1994) were detectable in 
some of the samples. The phosphoimager quantitation (B) of the amount of TCR-associated c in the two major forms (L-6 and c-FceRly) as percentage 
of total TCR-associated r is shown as a bar graph: closed square, (cpm L-[/total cpm L) x 100; shaded square, (cpm <-FcsRlyltotal cpm 5) x 
100. The degree of purity of the separated populations is shown in (C) after staining with PE-anti-CD3 and FITC-anti-CD8 for the purified CD8+ 
T cells from H-2” KB5.C20-Tg and BM3.3-Tg mice, and after staining with PE-anti-CD3 and biotyl-anti-N)<1 .l plus FITC-streptavidin for the 
separated NKl .l~ and NKl .l+ CD4dD8- T cells from H-2m BM3.3-Tg mice. 
H-2Uk samples expressed similar high level < mRNA (Fig- low c mRNA was also observed for T cells from H-2km 
ure 5, right, for mRNA quantitation relative to tubulin RAGP BM3.3-Tg-TCR mice (see Figure 4), indicating 
mRNA). The KB5.C20-Tg sample consistently had higher that the high (Fc~Rlyll;) mRNA ratio was dependent on 
FcERI~ mRNA than the BM3.3-Tg H-2kn sample. This may expression of the Tg-TCR and not on any endogenously 
be correlated with a slightly higher content of FccRlr pro- rearranged TCRs. The quantitation of this (FcsRlyIl;) 
tein, which is not associated with the Tg-TCR (Figure 5, mRNA ratio is shown with reference to that of the NK1 .l+ 
left) in these cells. In the H-2” KB5.C20-Tg CDCCDS- T cell population (see Figure 48). Even for a CD8+ T cell 
T cells, FcERI~ mRNA could barely be detected and the population (KB5.C20-Tg k/k) that expresses significant 
amount of < mRNA was similar to that present in H-2k/k FcERI~ mRNA (though 4-fold less than the NKl .l+ T cells; 
CD8+ T cells (Figure 5,’ right, see quantitation). The H-2Wb Figure 5) the (Fc.sRly/<) mRNA ratio was about 20-fold 
BM3.3-Tg NKl .l+ T cells clearly had the highest content lower. To establish whether in NKl .l+ T cells low mRNA 
of Fc&Rly mRNA and the lowest content of c mRNA (see was a characteristic of r;, the same blot (see Figure 4) was 
Figure4; Figure5). The BM3.3-Tg NKl .l-Tcell population further hybridized with CD3?, CD36, and CD3c probes. 
had a Northern profile that was intermediate between The results, expressed as ratios of CD~E, CD3S, or CD3y 
those of these two H-2Ub populations. The high FcERI~ and mRNA to < mRNA (see Figure 48, ratios with reference 
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Figure 4. Comparison of FcsRlu, 5, and CD3 mRNA in CfWCD6’ T 
Cells of H-2Uk Tg-TCR Mice and in NK1.1. or NK1.1’ CfWCD6~ T 
Cells of H-2Ub Tg-TCR Mice 
Peripheral T cell populations were purified (>90% pure) as described 
in Experimental Procedures and the following populations were ana- 
lyzed: CD6+ T cells from H-2m BM3.3-Tg (lane 1) or KE5.C20-Tg (lane 
2) mice; NKl .I CD4-CD6- T cells from H-2Vb KB5.C20-Tg (lane 3) or 
BM3.3-Tg (lane 4) mice; NK1.1’ CXWCDE- T cells from H-2Ub 
BM3.3-Tg mice (lane 5); CD4-CD6- T cells from RAGI-‘- H-2Ub 
BM3.3-Tg mice (lane 6). RNA was extracted and Northern blots were 
probed sequentially with cDNA for r, FcsRlT. tubulin, CD3s, CD36, 
and CD3T. Autoradiographs are shown in (A) for the Northern blots 
revealed with the first three probes and phosphoimager quantitation 
is shown in(B) as the ratio of the hybridization signal for FcsRlT, CD3s, 
CD36 and CD3v to i mRNA relative to the value for the BM3.3-Tg 
NKl .l+ (k/b) sample set at one. Results similar to those shown were 
obtained in two other experiments. The ratios of CDST/< (1.5 + 0.5). 
CD3Sq (1.3 f 0.4) and CD3dC (1.06 * 0.2) mRNA were very similar 
in the various samples (mean + SD for ratios from samples 1-5). 
Figure 5. Comparison of Total <and FcsRly Expression at the Protein 
and mRNA Level in the CD6+ and NKl .I or NKI .l+ CD4-CD6- T Cell 
Populations 
Data at the left (immunoprecipitation) show the phosphoimager quanti- 
tations of the TCR-associated r or FcsRly protein (data from Figure 
3) and, additionally, the quantitations of the total < or FceRly protein 
as determined by a subsequent immunoprecipitation with anti-6 or 
anti-FcaRly antibodies and blotting as in Figure 3 (data shown as cpm 
of total <or total FceRlu). The bottom shows the ratios of total FceRlr 
to total i protein, with the value for the NKl .l+ sample set at one. 
Data at the right (Northern blot) show the signals of c or FcsRly mRNA 
to tubulin mRNA obtained for each sample (data from Figure 4). The 
bottom shows the ratios of FcsRlT to 6 mRNA, with the value for the 
NKI .l+ sample set at one (as in Figure 48). 
to those of the NKl .l+ T cells), show that the expression 
of these mRNAs relative to 5 mRNA was rather constant 
in all T cell populations analyzed. This indicates that there 
was no selective switch off or instability of r; mRNA within 
the BM3.3-Tg NKl .l+ T cells. 
To compare further the expression of r and FcsRly pro- 
tein and mRNA, we present (Figure 5) in parallel thevalues 
for total 6 and FcERI~ as protein (associated or not with 
the TCR) and mRNA. From this, it is clear that the NKl .l+ 
T cells have the highest expression of total FcERI~ and 
the lowest expression of total 5 protein and mRNA, the 
ratio of (FcERI~/<) being more than five times that of any 
other population tested. 
Are High FccRlylr mRNA and Protein Ratio and 
FccRly Usage in the TCR-CD3 Complex 
Characteristics of Separate T Cell Lineages? 
The genes encoding rln and FCERIY are both located on 
chromosome 1, whereas other CD3 genes reside in close 
proximity on mouse chromosome 9 (Letourneur et al., 
1989). Little is known concerning the regulation of their 
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expression in T cells. However gene knockout studies in 
mice (Malissen et al., 1993; Ohno et al., 1993) showed 
that expression of the cjr protein, which is required at the 
final stage of the assembly of the TCR-CD3 complex, is 
needed for the development of mature thymocytes along 
the main CD4+/CD8+ pathway, whereas expression of 
FceRly is dispensable (Takai et al., 1994). Nevertheless 
thymus-independent gut intraepithelial lymphocytes de- 
veloped normally and expressed surface TCR-CD3 com- 
plexes in the Un-‘- mice (Malissen et al., 1993; Ohno et 
al., 1993) consistent with their usage of FcsRly homodi- 
mers in place of un homodimers in the TCRa8 complex 
(Guy-Grand et al., 1994). 
Other cells for which TCR-associated FcsRly homodi- 
mers and FcsRly-c heterodimers have been described 
are lymphokine-activated killer cells and IL-2-cultured 
CD4-CDB- NKl .l+ TCRa8 cells isolated from thymus or 
spleen (Koyasu et al., 1992; Koyasu, 1994), as well as the 
long term IL-2-cultured CTLL-2 line (Orloff et al., 1990). 
In these studies, it was possible that the extended periods 
of cell culture in IL-2 could contribute to Fc&Rly mRNA 
expression and usage of the encoded chain in the TCR 
complex. However, while we could confirm high Fc~Rly 
mRNA expression and usage of FczRly-c heterodimers by 
line CTLL-2, two mouse CD8+ T cell clones also main- 
tained in long term IL-2 culture in our laboratory expressed 
only ljrl dimers in association with the TCR (data not 
shown), indicating that IL-2 expansion does not necessarly 
induce usage of Fc~Rly. Collectively, these data suggest 
that high expression of Fc.sRly mRNA and low expression 
of < and CD3 mRNA as well as association of Fc~Rly chains 
with the TCR complex is a T cell lineage characteristic, 
rather than a postdifferentiation induction of gene expres- 
sion. A case where the latter has been suggested to occur 
is that of splenic T cells of tumor-bearing mice, reported 
to express only TCR-associated FcERI~ homodimers (Mi- 
zoguchi et al., 1992) or TCR-CD3 complexes lacking r/l 
chains (Aoe et al., 1995). 
We next examined the conditions for the selection of 
the NKl.l+ Tg-BM3.3 cells (Table 1) and addressed the 
question of their thymus dependence (Table 2). 
Evidence for Thymic-Dependent and 
CDB-Independent Selection Involved in the 
Development of the Tg-TCR/CD3bNK1 .l + T Cells 
The difference between the BM3.3-Tg-TCR and KB5.C20- 
Tg-TCR in generating Tg-TCR/CD$“NKl.l+ T cells in 
H-2ti mice cannot be accounted for by their usage of a 
particular V8 gene since both use Vf32 (Malissen et al., 
1986; Couez et al., 1991). However, the difference in CD8 
requirement for H-2Kb-dependent triggering of the two Tg- 
TCRs (Auphan et al., 1994) could be essential. 
The question as to whether an antigen-dependent selec- 
tion event was involved in the generation of Tg-TCR/ 
CD3’“NKl .l+ T cells, rather than the appearance of this 
lineage by default, when all other T cells are deleted, was 
addressed next. To evaluate this point, different crosses 
of BM3.3-Tg mice were analyzed. Since thymic cellularity 
is reduced in TCR-Tg mice expressing the H-2Kb antigen, 
the percentage and number of NKl .l+ cells was evaluated 
from three-color staining within the Tg-TCR+CD4CD8- 
population (Tables 1 and 2). First, it was verified that the 
expression of H-2b was sufficient to select Tg-TCRI 
CDS’ONKl .l+ T cells, as indicated by the presence of these 
cells in H-2Wb and H-2Wd mice, as in H-2Ub mice expressing 
the BM3.3-Tg-TCR. The range of percentage of NKl .l+ 
cells among BM3.3-Tg-TCR+CD4-CD8- cells was 30%- 
60% for thymocytes and 35%-45% for splenocytes in 
these mice (Table 1; data not shown). Next, it was estab- 
lished that the Tg-TCR+NKl.l+ T cells were present in 
CD8-‘- BM3.3-Tg-TCR H-2km mice (Table 1, values within 
the range for CD8+‘+ H-2k/b mice). Finally, it was observed 
that BM3.3-Tg-TCR mice expressing mutant H-2Kb 
(H-2KbmB), which leads to less stringent negative selection 
than H-2Kb, did not contain NKl .l+ Tg-TCR’ T cells (Table 
1). The latter is particularly interesting, since in BM3.3-Tg- 
TCR H-2UbmB mice, Tg-TCR+CD4-CD8- cells represent an 
important fraction of thymocytes and are found in abun- 
Table 1. Presence of NK1 .l+ CD4-CD8- EM3.3-Tg-TCR’ Cells in Thymus and Spleen as a Function of H-2 Alleles 
Thymocytes” Splenocytesa 
TCR Total Number Percent of Percent of NKl .l among Percent of Percent of NK 1 .l among 
Tg mice H-2 (x 10-3 Tg+CD4-CDW Tg+CD4-CDBmc Tg+CD4-CDW Tg+CD4-CD8-” 
Tg-BM3.3 k/b 4.5 38 (1.7) 60 (1.0) 13 42 
b/b 2.5 24 (0.6) 45 (0.3) 23 45 
b/d 4.0 52 (2.1) 32 (0.7) 23 37 
k/k 122 5.0 (6.0) 0 (0) 1.9 <I 
kJbm8 22 69 (15) 0.06 (<O.Ol) 14 <l 
TgBM3.3 CDW k/b 4.0 42 (1.7) 45 (0.8) 21 35 
a Total thymocytes and splenocytes were labeled with anti-CD4 andantiCD8. both FITC-conjugated, PE-conjugatedanti-NK 1 .l, biotin-anti-Tg-TCR, 
and streptavidin-Tricolor. Events (20,000) were recorded using a live gate. 
b Percent of total cells that are Tg-TCR+CD4-CD8-. The calculated absolute cell number is indicated in parenthesis (x 10-3 for the thymocytes. 
For splenocytes, cell numbers (x lo-3 in different groups varied between 120 and 60 as indicated in Figure 1. 
c Percent of NK 1 .l+ cells within the Tg-TCR’ CD4-CD8- population was calculated using the third-color histogram. The calculated absolute cell 
number is indicated in parenthesis (x 10-9 for the thymocytes. 
Mice were crosses between CBA/Ca mice homozygous for the Tg-EM3.3 and BlO.BR(k/k), BG(k/b), B6-H-2”B(klbm8); or of (Tg-BM3.3 CBAlCa 
x B6)Fl backcrossed with B6(b/b) or BlO.DP(b/d), or of Tg-BM3.3 CBA/Ca F2 crosses to COB-‘- KZ6 mice (Tg-BM3.3 CD6-‘+ k/b), 
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Table 2. Presence of NKl .l+ CD4-CD8- BM3.3-Tg-TCR’ Cells in Thymus and Spleen of Tg-TCR Bone Marrow Reconstituted Irradiated Mice 
Thymocytesa Splenocytes” 
Tg/TCR Total Number Percent of Percent of NKl .l among Percent of Percent of NK 1 .l among 
donor mice Recipient mice (x 1Om6) Tg+CD4-CDemb Tg+CD4-CD8-’ Tg+CD4-CDBmo Tg+CD4-CD8-” 
Tg-BM3.3 H-P 1.6 23 (0.4) 33 (0.12) 7.5 34 
H-2Wb H-2D’b 0.6 37 (0.2) 37 (0.08) 4.7 3.5 
H-2Wb ndnu NTa NTd NTa 1.3 1.7 
H-2”k 2.5 32 (0.8) 16 (0.12) 10 15 
a Total thymocytes and splenocytes were labeled with anti-CD4 and anti-CD8, both FITC-conjugated, PE-conjugated anti-NK 1 .l, biotin-anti-Tg-TCR 
and streptavidin-Tricolor. Events (20,000) were recorded using a live gate. 
’ Percent of total cells that are Tg-TCR’ CD4-CD8-. The calculated absolute cell number is indicated in parenthesis (x IOm6) for the thymocytes. 
For splenocytes, cell numbers (x IO-8) in different groups varied between 120 and 60 as indicated in Figure 1. 
’ Percent of NK 1 .l’ cells within the Tg-TCR’ CD4-CD8- population was calculated using the third-color histogram. The calculated absolute cell 
number is indicated in parenthesis (x 1O-8) for the thymocytes. 
d NT, not testable. 
Irradiated (10 Gy from a ‘Vs source) mice (CBA x B6)Fl (H-2Ub), B6 (H-2m), antymic B6 nu/nu (H-2Wb nuhu), or (CBA x BlO.BR)Fl (H-2Vk) were 
reconstituted with 10’ anti-Thy-l-depleted bone marrow cells from (Tg-BM3.3 CBA/Ca x B6)Fl mice and were analyzed 10 weeks after reconstitu- 
tion. Nonreconstituted control mice died within two weeks. Splenocyte reconstitution was more than 80% as assessed by the expression of H-2KL 
(MAb 100.5.28) or H-2Kb (MAb 20.8.4). Although not expressing Tg-TCR, NKI .l+ cells (NK cells) were present in the reconstituted nu/nu spleens 
(percent of NKl .l cells was 8.0,4.7,4.4, and 3.9, respectively, in the spleens of reconstituted [CBA x B6]Fl, B6, B6 nuhu, and [CBA x BlO.BR]Fl 
mice). 
dance in the periphery (Table l), yet less than 1% express 
the NK1.l marker. The H-2Kbms mutant molecule, which 
has been shown to present a set of peptides differing from 
those presented by H-2Kb (van Sleek and Nathenson, 
1991), is a poor stimulatory antigen for the BM3.3-Tg-TCR, 
in which case activation of mature Tg-TCR+CD8+ cells be- 
comes dependent on CD8 (data not shown). The develop- 
ment of 13M3.3-Tg-TCR/CD3’“NK1 .l+ T cells appears to 
depend, therefore, on the expression of the H-2Kb antigen 
and on a CDB-independent TCRICD3 triggering event. 
These cells, however, do not appear to accumulate in the 
thymus (see cell numbers in Table 1). 
The thymic dependence for their generation was exam- 
ined further. Transfers of T cell-depleted bone marrow 
cells from BM3.3-Tg-TCR H-2m mice into irradiated recipi- 
ents led to the appearance of Tg-TCR/CD3r”NK1 .l+ T cells 
in the thymus and spleen in (CBA x B6)Fl and in B6 mice 
(Table 2, the range of percentage of NKl .l+ cells among 
Tg-TCR’ CD4-CD8- cells was 29%-370/o for thymocytes 
and 29%-350/o for splenocytes in these mice in different 
experiments), but not in the spleen of B6 athymic nulnu 
mice (Table 2). Although evidence for adequate repopula- 
tion of the irradiated nulnu mice was difficult to evaluate 
on the basis of Tg-TCR’ cells, it could be assessed by 
the expression of the H-2Kk antigen on their splenocytes 
(Table 2, legend). Furthermore, NKl .l+ cells were present 
in the reconstituted nulnu spleens, but did not express 
Tg-TCR (Table 2). 
The characterization of the NKl .l+ T cells as thymus 
dependent, although from a particular intrathymic lineage, 
is consistent with the data of Koyasu and colleagues (Koy- 
asu et al., 1992; Koyasu, 1994). The results in Table 2 
also indicate that H-2b expression on cells of hematopoi- 
etic origin is probably sufficient to produce the NKl .l+ T 
cells, since about 15% of Tg-TCR+CDCCD8- cells ex- 
pressed the NKl .l marker in both thymus and spleen of 
irradiated H-2k mice reconstituted with T cell-depleted 
bone marrow from H-2Wb Tg-BM3.3 mice. The proportion 
of NKl .l T cells generated in these conditions is lower than 
that observed in transfers in H-2b expressing irradiated 
recipients. Thus, it is possible that antigen expressed on 
thymic stroma may also contribute to the stimulation of 
NK1.l cells when a classical class I MHC product is the 
nominal antigen. 
Proposed Scheme for the lntrathymic 
Ligand-Induced Selection of Subsets of CD4-CD8- 
Tg-TCR Lymphocytes 
In normal mice, the expression of the FCERIY gene appears 
to be switched off early in adult thymocyte development. 
It is detected only in the immature CD25- population, in 
which expression of the < gene is low, and not in immature 
CD25’ thymocytes, which have an increased expression 
of < mRNA (Guy-Grand et al., 1994). The pattern of the 
ratio of FcaRlrl~ mRNA expression (see Figure 4; Figure 
5) in the different CD4-CD8- populations is therefore com- 
patible with their selection at different intrathymic stages 
or on different lineages. A scheme which takes into ac- 
count the expression of maturation markers on CD4-CD8- 
cells in the thymus, the characteristics of Tg-TCRlligand 
interaction, the relative abundance of Fc&Rly/~ mRNA, and 
the usage of the FcsRly in association with the Tg-TCR 
of peripheral CD4-CD8- cells is proposed in Figure 6. 
From a common early (CD44+CD25HSA-) thymic pre- 
cursor (Godfrey et al., 1993; Koyasu, 1994) NKl .l+ and 
NKl .l- CD4-CD8- thymocytes would start their matura- 
tion in the thymuson separate paths. For the NKl .l+ cells, 
as soon as a sufficient level of surface TCR (TCR’“) is 
expressed, a strong TCR-ligand interaction would lead to 
expression of the ILQR8 and possibly other activation/ 
emigration markers, allowing them to leave the thymus 
as TCR-CD3r” (FcsRl$Qhi T cells. For the Tg-TCR models 
studied here, these conditions are fulfilled only for the 
BM3.3-Tg-TCR engaged by H-2Kb (so-called high avidity 
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antigen-TCR interaction). The presence of H-2Kbms would 
either not be perceived by these cells expressing low TCR 
and no CD8 or the engagement would not lead to the 
appropriate maturation signal. Similarly, on those cells H- 
2Kb fails to provide the KB5.C20-Tg-TCR (so-called low 
avidity antigen-TCR interaction) with the appropriate mat- 
uration signal. In its absence, as is the case in H-2”k mice 
in both Tg-TCR models, these cells may die, since few 
NKl.l+ T cells are found in these mice. The conditions 
defined here for this maturation step, which we found to 
occur in CD8-‘- mice (Tables 1 and 2), may be similar to 
those required for the development of (Va14) NKl.l+ T 
cells present in normal mice. This also occurs in CCW- 
mice and yet is dependent on the expression of a nonpoly- 
morphic class I MHC product (Bix et al., 1993; Bendelac 
et al., 1994), recently suggested to be CD1 (Bendelac et 
al., 1995). In thelattercase, Val4NKl .l+Tcellswere both 
CD4-CD8- and CD4+CD8- and may therefore additionally 
involve a selection step at a stage prior (CD47 or past 
(Bendelac et al., 1994) the one defined here, which gener- 
ates only CD4-CD8- NKl .l+ T cells (see Figure 2). 
The NKl.l- thymocytes found in H-2Wb BM3.3-Tg or 
KB5.C20-Tg mice express IL-2Rj3, but have a phenotype 
Figure 6. Proposed Scheme for the Intra- 
thymic Antigen-Induced Selection of Subsets 
of CD4-CD8- Tg-TCR Lymphocytes 
(CD25-CD44-HSA’) (see Figure 2) corresponding to a fur- 
ther maturation stage preceding the CD4’CD8+ stage (see 
Figure 6), being TCR/CD3’0 and TCFi/CD3h’, respectively 
for the BM3.3-Tg and the KB5.C20-Tg (see Figures 1 and 
2). Similarly to the cells from the NKl.l+ lineage, these 
cells would receive a maturation signal leading to IL-2FQ3 
expression when the Tg-TCR expression reaches a level 
at which it is stimulated by antigen. This would occur at 
the TCR’” stage for the BM3.3-Tg in the presence of H-2Kb 
and only later at the TCRhi stage for the BM3.3-Tg in the 
presence of H-2Kbms or the KB5.C20-Tg in the presence 
of H-2Kb, following the same TCR-ligand avidity rules as 
outlined above. It is consistent with a progressive reduc- 
tion in FcsRly mRNA and increase in r; and other CD3 
mRNAs on this lineage, so that peripheral Tg-TCR/CD3” 
CD4-CD8- from the KB5.C20-Tg express very low FcERI~ 
and high c mRNA (see Figures 4-5) and have essentially 
c-c homodimers associated with their Tg-TCR (see Figure 
3). This situation may be similar to the case of the H-Y/ 
H-2Db-specific Tg-TCR (von Boehmer et al., 1991), for which 
the Tg-TCR CD4CD8- T cells contain essentially c and 
no Fc~Rly mRNA (Guy-Grand et al., 1994). In the periph- 
ery, all the CD4-CD8- T cells expressed the IL-PRO as well 
Figure 7. Antigen-Dependent or Anti-TCR- 
Redirected Lysis by NK1.V and NK1.1’ 
SM3.3-Tg CD4-CD8- T Cells Cultured in IL-2 
CD4-CD8- T cells purified as described in Ex- 
perimental Procedures from pooled spleen and 
lymph node cells from K&C20-Tg (open 
square, closed square) or BM3.3-Tg H-2” 
mice, which had been further separated into 
NK1.V (open triangle, closed triangle) and 
NKl .l’ (open circle, closed circle) cells as in 
Figure 3 were cultured in APMI, 5% FCS me- 
dium alone (open symbols) or supplemented 
with rlL-2 at 10 p/ml (experiment A) or 100 p/ml 
(experiment B) for 48 hr. After harvesting, cells 
were assayed in a classical 4 hr %r release 
I:, 3.1 v:, 
Effector to target ratio 
1.1 3:1 VI 
Effector to target cell ratio 
I:, J:, v:, 
Effector to target ratio 
cytotoxic assay using as target cells the RMA 
lymphoma (H-2b expressing) or the peptide 
transporter-deficient AMAs mutant lymphoma 
line, in experiment A and the RMA lymphoma as well as Li210 cells (H-2d-expressing lymphoma) in the presence of 10 pglml MAb directed at 
the KB5C20 TCR or at the BM3.3 TCR, in experiment B. The percentage of specific Wr released from the target cells is shown for different 
effector to target cell ratios. Ex viva assays of cytotoxicity in 4 hr %r release assays using the H-2KD-bearing target cells RMA, the Fas-expressing 
LlPlO-Fas target cells, or the NK-sensitive YAC target cells were all negative. 
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as CD44 at their surface and were HSA- (data not shown), 
suggesting a further maturation step for the CD4-CD6- 
NKl.l- cells upon their migration to the periphery (see 
Figure 6). 
For both Tg-TCR models in the absence of antigen 
(H-2”k mice), CD4-CD6- Tg-TCRICDS” thymocytes are 
CD25-CD44-HSA+ and lack expression of the IL-2RP (data 
not shown; Figure 6). This agrees with the notion that IL- 
2RP expression on CD4-CD6- thymocytes results from 
intrathymic self-recognition (Hanke et al., 1994). Here, the 
H-2k structures capable of signaling the Tg-TCR for posi- 
tive selection on the CD4+CD6+ lineage are incapable of 
inducing asignal in the CD4-CD6- lineage, consistent with 
the CD6 coreceptor dependence for positive selection 
(Fung-Leung et al., 1993; Curnow et al., 1994). 
This model suggets the existence of a “window” during 
early adult thymocyte differentiation in which TCR engage- 
ment would lead to activation/selection along a pathway 
distinct from the main CD4+CD6+ pathway, rather than 
deletion (von Boehmer et al., 1991; Takahama et al., 
1992). In both Tg-TCR models, thymocytes that progress 
expressing the Tg-TCR along the main pathway of differ- 
entiation beyond this window would be deleted. 
Both Tg-TCRs studied here are under the control of the 
TCRP gene enhancer (Schanrich et al., 1991; Auphan et 
al., 1994) with premature expression of the Tg-TCRa gene. 
This property, therefore, is not sufficient to generate the 
TCRaB CD4-CD6-NKl .l+ pathway. It may, however, be 
necessary in both Tg-TCR and non-Tg mice. Little is known 
about TCRaP gene expression on the CD4-CD6- develop- 
mental pathway(s) (Capone et al., 1995) and it has not 
been excluded that the restriction in the VaNP repertoire 
observed in the CD4-CD6- lineage(s) might result from 
the requirement for early Vu rearrangement/expression 
and antigen selection. This possibility remains to be tested 
in normal mice. 
TCRaP CD4-CDS- T cells have been described in the 
periphery in pathological states associated with autoim- 
munity (Shivakumar et al., 1969), or autologous tumor 
growth (Seki et al., 1991). It is not clear, however, whether 
the presence of these cells is related to the “anergy” of 
the immune system towards autoantigens or autologous 
tumor antigens or, on the other hand, whether it contri- 
butes to effector mechanisms in pathological autoimmu- 
nity or in autologous tumor rejection. 
The Fc&Rlr protein belongs to the same family of hema- 
topoietic cell receptor components as 5, but contains only 
one YXXUI immuno-receptor tyrosine-based activation 
motif (ITAM) (for review see Malissen and Schmitt- 
Verhulst, 1993), as opposed to three in 1;. This, in addition 
to low TCRlCD3 expression on the BM3.3-Tg NK1.1’ T 
cellscould contribute to impaired Tcell function and opera- 
tional anergy towards antigenic stimulation. We observed 
that the BM3.3-Tg-TCR/CD3’0 NKl.l+ (as well as the 
NKl.l-)peripheralTcellsdid notexhibitanycytolyticfunc- 
tion ex vivo through any of the known cytolytic pathways, 
which include Fas-dependent, perforin-dependent, or NK- 
type lysis (Figure 7, legend). Addition of IL-2 (10 or 100 
k/ml for 46 hr) to cultures of either NKl.l+ or NKl.l- 
BM3.3-Tg-TCR CD4-CDE- H-2Ub cells was required for 
their development into CTL lysing specifically H-2Kb- 
expressing tumor target cells (Figure 7). Antigen-specific 
cytolysis was not observed for IL-2 cultured KB5.C20-Tg- 
TCR CD4-CD6- cells (Figure 7), as previously discussed 
(Auphan et al., 1992,1994). Thus, theTCRICD3’” CD4-CD6- 
NKl .l+ T cells can be triggered by their cognate antigen 
to induce target cell lysis, indicating that the FcsRly/l;- 
associated BM3.3-Tg-TCR can be functional in response 
to antigen. It remains to be determined whether such reac- 
tivity may be elicited in vivo in the presence of cytokines 
and whether it would lead to some form of autoreactivity. 
Experimental Procedures 
Mice 
Normal mice were (CBA/Ca x B6)Fl. KE5.C20-Tg H-2Wk or H-2Lm were 
Fl crosses between BlO.BR mice homozygous for the KB5.C20-Tg 
(Schbnrich et al., 1991) and CBAlCa or C57EU6 (66) mice, respec- 
tively. BM3.3-Tg H-2Wk or H-2”‘” were Fl crosses between CBA/Ca mice 
homozygousfor the BM3.3-Tg (Auphan et al., 1994) and, BlO.BR and 
86 mice, respectively. These mice, as well as BlO.D2 and B6-H-2b”B 
were bred in our animal facility. Tg-BM3.3 CD8-‘- mice were derived 
as described (Curnow et al., 1994). Athymic B6 nolnu mice were pur- 
chased from Biological Research Laboratories (Basel, Switzerland). 
All mice used in this study expressed the NKI .l allele, except for the 
BM3.3-Tg H-2Wb RAGV mice, which were generated from crosses 
between CBA/Ca mice homozygous for the BM3.3-Tg and RAGl~‘- 
mice (strain 1291Sv) (Mombaerls et al., 1992). 
Antibodies 
Monoclonal antibodies (MAb) used in this study for cell staining. cell 
purification, or immunoprecipitation were, as previously referenced 
(Curnow and Schmitt-Verhulst, 1994), DBsirC-I, anti-KBB.CPO clono- 
type; Ti98, anti-BM3.3 clonotype; H129.19.6. anti-CD4; H59.101.2. 
anti-CD8a; 145.2Cl I, anti-CD3s; Ml .69, anti-HSA; PC61, anti-IL-2Ra 
(CD25); H194.17.3, anti-pgp-1 (CD44); as well as RA3.682, anti-B220 
(Coffman and Weissman. 1981); Ml .70, anti-Mac-l (Springer et al., 
1978); RB6.8C5, anti-GR-1 (Jutila et al., 1988); 2.462, anti-FWRIII 
FcyRlll (Unkeless, 1979); H146.968 anti-c chain (Rozdial et al., 1994); 
H57, anti-TCR8 (Kubo et al., 1989); PK136, anti-NKl .I (Koo and Pep- 
pard, 1984); TM-PI anti-IL-2RP (Tanaka et al., 1991). 
Flow Cytometric Analysis 
For each sample 5 x lo5 thymocytes or spleen cells were incubated 
sequentially (20 min each at 4%) with optimal concentrations of phy 
coerythrin (PE)-conjugated anti-NK1.l (PK136, Pharmingen), anti- 
CD4, or anti-CD8 (Boehringher Mannheim, Mannheim, Federal Re- 
public of Germany); fluorescein isothiocyanate (FITC)-conjugated 
anti-CDSs, anti-HSA, antiCD44, anti-IL9Ra (CD25), or anti-IL-PRP; 
biotin-anti-TCR, and streptavidin-Tricolor. The anti-TCR antibodies 
used were H57 (anti-TCRP), D&i&l (anti-KB5.C20 clonotype). and 
Ti98 (anti-BM3.3 clonotype), for samples from normal, KB5.C20-Tg, 
and BM3.3-Tg, respectively. After each step there was awash in phos- 
phate-buffered saline (PBS), 0.2% bovine serum albumin (BSA), 
0.02% NaN3. with two final washes. Ceils were kept on ice until flow 
cytometric analysis, which was performed on a FACScan (Becton Dick- 
inson, Mountain View, California). Data were collected and analyzed 
using Lysis II software (Becton Dickinson). 
Cell Fractionation 
Cells were purified from pooled spleen and lymph node populations 
by magnetic activated cell sorting (MACS, Miltenyi Biotec), using com- 
binations of biotinylated MAb followed by streptavidin-FITC and biotin 
magnetic microbeads, according to the instructions of the manufac- 
turer, with the isolation of those cells that were positive or negative 
for the indicated molecules. In Figure 3, CD4-CD8+ T cells from H-2m 
KB5.C20-Tg and BM3.3-Tg mice were purified using negative selec- 
tion as follows: CD4-, B220-, Mac-l-, GR-1 , F~Rlll FcyRIII‘. Total 
CD4 CD8- and CD4-CDB-NKI .I H-2M KB5.C20Tg peripheral T cells 
were obtained as above plus, respectively, a second sequential MACS 
purification for CD8- and for CD8- and NKI .I -_ For the H-2” BM3.3-Tg 
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peripheral T ceils, total CD4CD6- and CD4-CD6- NKl .I populations 
were obtained as for H-Zm KB5.C20-Tg; in addition, the CD4CD6- 
NKI. l+ population was purified by positive selection with the MACS. 
In Figure 4, purification was as in Figure 3, except that the following 
antibody combinations were additionally used for positive (plus) or for 
negative (minus) selection. For KB5.C20-Tg H-2”‘kand BM3.3Tg H-2*, 
positive selection for CDB’; for KBS.C20-Tg H-2”, negative selection 
for CD4-, CDB-, NKl .l-, FcyRIIIIII-, and positive selection for Tg-TCR’; 
for BM3.5Tg H-2m, negative selection for CD4-, CD6-, F~RII/III-, 
followed by selection with anti-NKl .I for NKl .l+ cells (positive selec- 
tion), with the NKl .l- population (negative selection) further purified 
for Tg-TCR+. Separation into NKl .l+ and NKl .I - subpopulations was 
not possible for T cells from the RAGI-‘- mice because of their genetic 
background (Mombaerts et al., 1992). 
lmmunoprecipitation and Western Blotting 
Purified T cells (20 x lo8 for each lane) were lysed in 1% Brij96 lysis 
buffer. Lysates were immunoprecipitated as described (Buferne et al., 
1992) with 10 ug of specific anti-TCR MAb and protein A sepharose 
(Desire-l for KB5.C20-Tg mice [Hua et al., 19661, and Ti96 for 
BM3.3-Tg mice [Buferne et al., 19921) before SDS-PAGE (12.5% 
acrylamide) electrophoresis in nonreduced conditions. Blotting was 
performed on PVDF (Immobilon P, Millipore), (6 hr at 350 mA), using 
a CAPS buffer (10 mM [pH 1 l]), at 4OC. Blots were blocked with 3% 
BSA in PBS, and incubated in the same buffer with 1 uglml H146.966 
MAb specific for the < chain (Rozdial et al., 1994) or 11500 dilution of 
the rabbit anti-FcaRly antiserum (Orloff et al., 1990). Specific antibody 
binding was revealed with ‘%I protein A (7 x lo5 cpmlml in PBS; 
BSA 3%) and quantified with a phosphoimager (Fuji X-bas 1000, Fuji, 
Tokyo, Japan) and autoradiography (Fuji medical X-ray film, Fuji). 
Northern Blot Analysis 
RNA was extracted from T cell populations purified as described above 
(>90% pure) and Northern blots were probed sequentially with cDNA 
for 5, FcsRly, tubulin, CD3&, CD36, and CD3T after oligolabeling as 
described (Buferne et al., 1992). FceRlT (Ra et al., 1969) cDNA was 
received from J.-P. Kinet, the other cDNAs were those previously used 
(Buferne et al., 1992). Northern blot quantitations were done using a 
phosphoimager (Fuji X-bas 1000, Fuji, Tokyo, Japan). 
Cytotoxicity Assay 
Tumor target cells and 4 hr 5Cr release cytolysis assays were as 
described (Auphan et al., 1994). The RMA lymphoma cell (H-2b ex- 
pressing) or its peptide transporter-deficient RMAs mutant lymphoma 
line, previously shown not to be recognized bythe KB5.C20and BM3.3 
TCRs (Guimezanes et al., 1992) were used as well as L1210 cells 
(H-2d-expressing lymphoma). 
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